Adia Nutrition Inc. Celebrates Adia Med's Approval as a UnitedHealthcare Provider in $5.3 Trillion Healthcare Market
Adia Nutrition Inc. (OTCQB: ADIA) has announced that its healthcare clinic, Adia Med, has received approval as a UnitedHealthcare provider, effective August 1, 2025. This strategic development positions Adia Med within the $5.3 trillion U.S. healthcare market, enabling access to its regenerative medicine treatments for UnitedHealthcare members.
Located in Winter Park, Florida, Adia Med specializes in minimally invasive therapies for orthopedic injuries, chronic pain, and wound repair. The clinic is staffed by physicians and Advanced Practice Registered Nurses (APRNs), offering personalized care using regenerative medicine treatments. The company is also seeking strategic partnerships and offering licensing opportunities for clinic owners interested in integrating Adia's regenerative therapies.
Adia Nutrition Inc. (OTCQB: ADIA) ha annunciato che la sua clinica sanitaria, Adia Med, ha ottenuto l'approvazione come fornitore di UnitedHealthcare, a partire dal 1 agosto 2025. Questo sviluppo strategico colloca Adia Med all'interno del mercato sanitario statunitense da 5,3 trilioni di dollari, permettendo ai membri di UnitedHealthcare di accedere ai suoi trattamenti di medicina rigenerativa.
Situata a Winter Park, Florida, Adia Med 猫 specializzata in terapie minimamente invasive per lesioni ortopediche, dolore cronico e riparazione delle ferite. La clinica 猫 composta da medici e infermieri specializzati (APRNs), offrendo cure personalizzate attraverso trattamenti di medicina rigenerativa. L'azienda sta inoltre cercando partnership strategiche e offre opportunit脿 di licenza per i proprietari di cliniche interessati a integrare le terapie rigenerative di Adia.
Adia Nutrition Inc. (OTCQB: ADIA) ha anunciado que su cl铆nica de salud, Adia Med, ha sido aprobada como proveedor de UnitedHealthcare, efectivo a partir del 1 de agosto de 2025. Este desarrollo estrat茅gico posiciona a Adia Med dentro del mercado de salud de EE. UU. valorado en 5.3 billones de d贸lares, permitiendo que los miembros de UnitedHealthcare tengan acceso a sus tratamientos de medicina regenerativa.
Ubicada en Winter Park, Florida, Adia Med se especializa en terapias m铆nimamente invasivas para lesiones ortop茅dicas, dolor cr贸nico y reparaci贸n de heridas. La cl铆nica cuenta con m茅dicos y enfermeros practicantes avanzados (APRNs), ofreciendo atenci贸n personalizada mediante tratamientos de medicina regenerativa. La compa帽铆a tambi茅n busca alianzas estrat茅gicas y ofrece oportunidades de licencia para propietarios de cl铆nicas interesados en integrar las terapias regenerativas de Adia.
Adia Nutrition Inc. (OTCQB: ADIA)電� 鞛愳偓鞚� 項姢旒�鞏� 韥措Μ雼� Adia Med臧赌 2025雲� 8鞗� 1鞚�攵�搿� UnitedHealthcare 鞝滉车鞛愲 鞀轨澑氚涭晿雼り碃 氚滍憸頄堨姷雼堧嫟. 鞚� 鞝勲灥鞝� 氚滌爠鞚� Adia Med毳� 氙戈淡 5.3臁� 雼煬 項姢旒�鞏� 鞁滌灔 雮挫棎 鞙勳箻鞁滍偆氅�, UnitedHealthcare 須岇洂霌れ澊 鞛儩 鞚橅暀 旃橂鞐� 鞝戧芳頃� 靾� 鞛堧弰搿� 頃╇媹雼�.
頂岆毽嫟欤� 鞙堩劙韺岉伂鞐� 鞙勳箻頃� Adia Med電� 鞝曧槙鞕戈臣 攵�靸�, 毵岇劚 韱奠 氚� 靸侅矘 旃橂毳� 鞙勴暅 斓滌唽 旃姷 旃橂毳� 鞝勲鞙茧 頃╇媹雼�. 鞚� 韥措Μ雼夓潃 鞚橃偓鞕� 瓿犼笁 鞁る 臧勴樃靷�(APRNs)搿� 甑劚霅橃柎 鞛堨溂氅�, 鞛儩 鞚橅暀 旃橂毳� 韱淀暣 毵烄钉順� 旒�鞏措ゼ 鞝滉车頃╇媹雼�. 須岇偓電� 霕愴暅 鞝勲灥鞝� 韺岉姼雱堨嫮鞚� 氇儔頃橁碃 鞛堨溂氅�, Adia鞚� 鞛儩 旃橂毳� 韱淀暕頃橂牑電� 韥措Μ雼� 靻岇湢欤茧ゼ 鞙勴暅 霛检澊靹犾姢 旮绊殞霃� 鞝滉车頃橁碃 鞛堨姷雼堧嫟.
Adia Nutrition Inc. (OTCQB: ADIA) a annonc茅 que sa clinique de sant茅, Adia Med, a 茅t茅 approuv茅e en tant que fournisseur UnitedHealthcare, 脿 compter du 1er ao没t 2025. Cette avanc茅e strat茅gique positionne Adia Med sur le march茅 am茅ricain de la sant茅 de 5,3 billions de dollars, permettant aux membres de UnitedHealthcare d'acc茅der 脿 ses traitements de m茅decine r茅g茅n茅rative.
Situ茅e 脿 Winter Park, en Floride, Adia Med est sp茅cialis茅e dans les th茅rapies peu invasives pour les blessures orthop茅diques, la douleur chronique et la cicatrisation des plaies. La clinique est compos茅e de m茅decins et d'infirmiers praticiens avanc茅s (APRNs), offrant des soins personnalis茅s gr芒ce 脿 des traitements de m茅decine r茅g茅n茅rative. L'entreprise recherche 茅galement des partenariats strat茅giques et propose des opportunit茅s de licence aux propri茅taires de cliniques souhaitant int茅grer les th茅rapies r茅g茅n茅ratives d'Adia.
Adia Nutrition Inc. (OTCQB: ADIA) hat bekannt gegeben, dass seine Gesundheitsklinik Adia Med ab dem 1. August 2025 als UnitedHealthcare-Anbieter zugelassen ist. Diese strategische Entwicklung positioniert Adia Med im 5,3 Billionen US-Dollar schweren US-Gesundheitsmarkt und erm枚glicht UnitedHealthcare-Mitgliedern den Zugang zu seinen regenerativen Medizinbehandlungen.
Adia Med mit Sitz in Winter Park, Florida, spezialisiert sich auf minimalinvasive Therapien bei orthop盲dischen Verletzungen, chronischen Schmerzen und Wundheilung. Die Klinik wird von 脛rzten und Advanced Practice Registered Nurses (APRNs) betreut und bietet personalisierte Versorgung mit regenerativen Medizinbehandlungen. Das Unternehmen sucht zudem strategische Partnerschaften und bietet Lizenzm枚glichkeiten f眉r Klinikinhaber, die Adias regenerative Therapien integrieren m枚chten.
- Secured provider status with major insurance company UnitedHealthcare
- Access to vast network of UnitedHealthcare members as potential patients
- Operating in a substantial $5.3 trillion healthcare market
- Offering licensing opportunities for business expansion
- Currently limited to single location in Winter Park, Florida
Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its healthcare clinic, Adia Med, has been officially approved as a provider with UnitedHealthcare, effective as of August 1, 2025. This significant milestone positions Adia Med within the
UnitedHealthcare Logo
Cannot view this image? Visit:
https://images.newsfilecorp.com/files/10520/261181_unitedhealthcare_sign.jpg
Adia Med's integration into UnitedHealthcare's expansive network enhances its ability to deliver cutting-edge, minimally invasive therapies that promote faster recovery with minimal downtime, addressing conditions such as joint pain, sports injuries, and chronic wounds. This approval underscores Adia Nutrition's commitment to transforming patient care through regenerative solutions, ensuring patients can resume their active lifestyles efficiently and effectively.
"We are thrilled to join UnitedHealthcare's vast provider network, a pivotal step in bringing our regenerative treatments to a broader audience in this
Located in Winter Park, Florida, Adia Med is staffed by experienced physicians and autonomous Advanced Practice Registered Nurses (APRNs) who provide personalized, patient-centered care. The clinic leverages the latest advancements in regenerative medicine to address complex conditions, ensuring high-quality outcomes.
For questions, inquiries, or additional information, please contact Larry Powalisz at [email protected] or by phone at 321-788-0850.
Clinic owners and healthcare practitioners interested in licensing the Adia Med name or integrating Adia's regenerative therapies into their practice are encouraged to reach out directly. Strategic partnerships are welcomed as part of Adia's continued mission to expand access to advanced stem cell solutions.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website:
Website:
Website:
Website:
Website:
Twitter (X):
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit
FAQ
When did Adia Med become a UnitedHealthcare provider?
What treatments does Adia Med (OTCQB: ADIA) offer?
What is the market size for Adia Med's healthcare services?
How can healthcare practitioners partner with Adia Med?
Where is Adia Med's clinic located?
